Acesso livre
Acesso livre

Medicina de Família

Revisão sistemática | Frequência, sinais, sintomas e critérios adotados para determinar “long COVID-19”.

9 Jun, 2021 | 09:53h

Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review – International Journal of Clinical Practice


M-A | “Hospital em casa” para pacientes com doenças crônicas que se apresentam ao departamento de emergência – Em comparação com a internação hospitalar, há risco similar de mortalidade, menor risco de readmissão e de admissão de longo prazo, além de menores índices de depressão e ansiedade.

9 Jun, 2021 | 09:51h

Hospital-at-Home Interventions vs In-Hospital Stay for Patients With Chronic Disease Who Present to the Emergency Department: A Systematic Review and Meta-analysis – JAMA Network Open

Comentário convidado: Hospitalization at Home for Patients With Acute Exacerbation of Chronic Disease—Further Evidence to Inform Practice – JAMA Network Open

Relacionado: Pandemic Boosts an Old Idea—Bringing Acute Care to the Patient E Randomized trial: Admission Avoidance Hospital at Home + Geriatric Assessment led to similar outcomes compared to hospital admission for older persons E Most COVID-19 patients receiving home-based hospital care did not require escalation to traditional hospital setting – Approximately 1 in 5 were admitted within 14 days. Higher oxygen saturation was associated with decreased odds of transfer, whereas higher comorbidity burden was associated with increased risk.


Aprovação do FDA para medicamento contra o Alzheimer gera controvérsia entre médicos.

9 Jun, 2021 | 09:49h

Comunicado de imprensa: FDA Grants Accelerated Approval for Alzheimer’s Drug – U.S. Food & Drug Administration

Comentários: ICER Issues Statement on the FDA’s Approval of Aducanumab for Alzheimer’s Disease – Institute for Clinical and Economic Review E Landmark Alzheimer’s Drug Approval Confounds Research Community – Nature E FDA approves Alzheimer’s drug from Biogen, against experts’ advice – NBC News E F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works – The New York Times (alguns artigos gratuitos por mês) E Alzheimer’s drug approved despite doubts about effectiveness – Science (alguns artigos gratuitos por mês) E The FDA Has Approved A New Alzheimer’s Drug — Here’s Why That’s Controversial – NPR E Opinion: Bad medicine: aducanumab is a lackluster drug with a high price tag – STAT


Não foi observado aumento nos problemas de saúde em bebês cujas mães foram vacinadas contra a gripe durante a gestação.

9 Jun, 2021 | 09:47h

No health issues in babies whose moms got flu vaccine while pregnant – CIDRAP

Estudo original: Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes – JAMA (gratuito por tempo limitado)

Editorial: Realizing the Potential of Maternal Influenza Vaccination (gratuito por tempo limitado)

 

Comentário no Twitter

 


Resumo | Recomendações da OMS para o tratamento da tuberculose resistente a medicamentos, atualização de 2020.

9 Jun, 2021 | 09:44h

World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update – European Respiratory Review

Diretriz original: WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment – Drug-Resistant Tuberculosis Treatment

 

Comentário no Twitter

 


Condições médicas subjacentes associadas à COVID-19 grave em crianças – Os principais fatores de risco para hospitalização foram doenças crônicas e complexas, diabetes tipo 1 e obesidade.

8 Jun, 2021 | 10:31h

Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children – JAMA Network Open

Comentários: Underlying illness, respiratory infection raise risk for severe COVID in kids – CIDRAP E COVID-19 in Children—Not Just Little Adults – JAMA Network Open

 

Comentário no Twitter

 


Relato | 376.000 pessoas no Reino Unido tiveram sintomas de “long Covid” por, pelo menos, 1 ano.

8 Jun, 2021 | 10:25h

376,000 people in UK have had long Covid symptoms for at least a year – ONS – The Guardian

Relatório original: Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 4 June 2021 – Office for National Statistics


Valor das manifestacões cutâneas no diagnóstico pelo SARS-CoV-2 – Houve uma associação significativa entre rash cutâneo e teste positivo (odds ratio 1,67).

8 Jun, 2021 | 10:24h

Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection – British Journal of Dermatology


Prática | Acne relacionada ao uso de máscara (“mascne”) e outras dermatoses faciais.

8 Jun, 2021 | 10:24h

Mask related acne (“maskne”) and other facial dermatoses – The BMJ

 

Comentário no Twitter

 


Sinopse | Atualizações das diretrizes de tratamento da asma pediátrica.

8 Jun, 2021 | 10:22h

Updates to the Pediatrics Asthma Management Guidelines – JAMA Pediatrics (gratuito por tempo limitado)

Diretriz original: 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.